5:41 PM
Feb 29, 2008
 |  BC Extra  |  Clinical News

Researchers start Tykerb, Herceptin trial

A pair of research groups began the Phase III ALTTO trial in 8,000 breast cancer patients. The open-label, international trial will compare four...

Read the full 93 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >